Revenue
Cost
Profit
| Item | Category | Value | YoY |
|---|---|---|---|
| Net sales | revenue | 7.71B | 0.73% |
| Gross profit | profit | 1.27B | -19.59% |
| Cost of product and service sold | cost | 6.44B | 6.00% |
| Net periodic defined benefits expense (reversal of expense), excluding service cost component | cost | 8.00M | -11.11% |
| Operating profit | profit | 253.00M | -54.25% |
| Selling, general and administrative expense | cost | 961.00M | -1.23% |
| Restructuring costs and asset impairment charges | cost | 54.00M | 260.00% |
| Aggregate | revenue | 261.00M | -53.56% |
| Income before income taxes | profit | 84.00M | -78.46% |
| Interest expense, net | revenue | 166.00M | -0.60% |
| Other expense, net | revenue | 11.00M | 120.00% |
| Net income (loss) attributable to noncontrolling interest | cost | 2.00M | 0.00% |
| Net income | profit | 63.00M | -83.51% |
| Income tax expense (benefit) | cost | 21.00M | 162.50% |
| Net income attributable to common shareholders | profit | 65.00M | -83.07% |
| Segment | Value | YoY |
|---|---|---|
| North America | 4.41B | -3.74% |
| Europe, Middle East and Africa, And Asia-Pacific | 2.77B | 7.34% |
| Latin America | 540.00M | 7.57% |
| Segment | Value | YoY |
|---|---|---|
| Packaging | 6.20B | 2.07% |
| Paper | 1.51B | -4.42% |
| Item | Category | Value | YoY |
|---|---|---|---|
| Accounts receivable, net (amounts related to consolidated variable interest entities of $834 million and $876 million at march 31, 2026 and december 31, 2025, respectively) | assets | 4.64B | |
| Inventories | assets | 3.58B | |
| Other current assets | assets | 1.65B | |
| Cash and cash equivalents (amounts related to consolidated variable interest entities of $6 million and $3 million at march 31, 2026 and december 31, 2025, respectively) | assets | 674.00M | |
| Total current assets | assets | 10.55B | |
| Property, plant and equipment, net | assets | 22.90B | |
| Goodwill | assets | 7.19B | |
| Other non-current assets (amounts related to consolidated variable interest entities of $393 million and $393 million at march 31, 2026 and december 31, 2025, respectively) | assets | 2.85B | |
| Intangibles, net | assets | 1.04B | |
| Prepaid pension asset | assets | 642.00M | |
| Assets | assets | 45.17B | |
| Liabilities | liabilities | 27.09B | |
| Total equity | liabilities | 18.08B | |
| Non-current debt due after one year (amounts related to consolidated variable interest entities of $369 million and $376 million at march 31, 2026 and december 31, 2025, respectively) | liabilities | 13.28B | |
| Total current liabilities | liabilities | 7.31B | |
| Deferred tax liabilities | liabilities | 3.41B | |
| Other non-current liabilities (amounts related to consolidated variable interest entities of $335 million and $335 million at march 31, 2026 and december 31, 2025, respectively) | liabilities | 2.40B | |
| Liability, defined benefit plan, noncurrent | liabilities | 686.00M | |
| Noncontrolling interests | liabilities | 25.00M | |
| Total shareholders’ equity | equity | 18.06B | |
| Accumulated other comprehensive loss | equity | 401.00M | |
| Treasury stock, common, value | equity | 34.00M | |
| Accounts payable | liabilities | 3.34B | |
| Other current liabilities | liabilities | 1.52B | |
| Current portion of debt | liabilities | 980.00M | |
| Accrued compensation and benefits | liabilities | 832.00M | |
| Accrued expenses | liabilities | 636.00M | |
| Aggregate | equity | 18.49B | |
| Capital in excess of par value | equity | 16.09B | |
| Retained earnings | equity | 2.40B | |
| Common stock, $0.001 par value; 9,500,000,000 shares authorized; 524,457,866 and 522,310,486 shares outstanding at march 31, 2026 and december 31, 2025, respectively | equity | 1.00M |
| Item | Value |
|---|---|
| Depreciation, depletion and amortization | 728.00M |
| Increase (decrease) in inventories | 101.00M |
| Net income | 63.00M |
| Impairment of assets | 35.00M |
| Share-based compensation expense | 28.00M |
| Other | -3.00M |
| Cash surrender value expense increase in excess of premiums paid | -4.00M |
| Pension and other postretirement funding more than cost | -27.00M |
| Deferred income tax expense (benefit) | -36.00M |
| Accounts payable | -44.00M |
| Increase (decrease) in other operating assets | -48.00M |
| Income taxes | -48.00M |
| Accrued liabilities and other | -143.00M |
| Increase (decrease) in accounts receivable | -398.00M |
| Item | Value |
|---|---|
| Proceeds from sale of property, plant and equipment | 9.00M |
| Proceeds from corporate owned life insurance | 3.00M |
| Payment for (proceeds from) other investing activity | 3.00M |
| Payments to acquire businesses, net of cash acquired | -18.00M |
| Payments to acquire productive assets | -624.00M |
| Item | Value |
|---|---|
| Changes in commercial paper, net | 507.00M |
| Additions to debt | 48.00M |
| Proceeds from re-issuance of shares from treasury stock | 14.00M |
| Other debt additions (repayments), net | 5.00M |
| Other | 1.00M |
| Payments of debt issuance costs | -3.00M |
| Finance lease, principal payments | -14.00M |
| Repayments of debt | -29.00M |
| Payment, tax withholding, share-based payment arrangement | -83.00M |
| Payments of dividends | -237.00M |
| Item | Value |
|---|---|
| Cash and cash equivalents, beginning of period | 892.00M |
| Cash and cash equivalents, end of period | 674.00M |
Instantly decode complex 10-K and 10-Q data. Explore interactive Sankey diagrams for income and balance sheets, and intuitive waterfall charts for cash flows.
Search for a company and select a report on the left panel.
Request Stock Support